Sign in

NCT07595809Recruiting

Dietary Intervention and Physical Activity in Patients With Heart Failure and Reduced Ejection Fraction

Source: ClinicalTrials.gov · Last updated 19 May 2026

Brief summary (registry, in English)

Heart failure with reduced ejection fraction (HFrEF) is frequently associated with abnormalities in body composition, including reduced skeletal muscle mass and sarcopenia, which are independent predictors of reduced exercise tolerance, impaired quality of life, and increased mortality. Despite advances in pharmacological therapy, evidence-based non-pharmacological strategies aimed at preventing muscle mass loss remain limited. This randomized controlled trial aims to evaluate the effects of dietary intervention based on the DASH diet with high-protein elements, resistance exercise training, and their combination on skeletal muscle mass, functional capacity, echocardiographic parameters, biochemical markers, and quality of life in patients with HFrEF.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
100 (estimated)
First submitted
13 May 2026
Start date
8 May 2023
Primary completion date
31 Jul 2026
Lead sponsor
Medical University of Silesia
NCT number
NCT07595809

What you commit to

  • Study type: Interventional
  • Planned participants: 100
  • From 8 May 2023 to the primary completion date, 31 Jul 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Lab values

  • NYHA functional class IV heart failure Potentially reversible cause of heart failure Estimated glomerular filtration rate \<30 mL/min Severe anemia (hemoglobin \<9 g/dL) Uncontrolled thyroid disease Severe hepatic dysfunction History of hyperkalemia or hyperkalemia at baseline Epilepsy Presence of joint endoprostheses Gastrointestinal disorders limiting adherence to the DASH diet Physical limitations precluding participation in structured exercis

Who the study is looking for

  • Written informed consent obtained prior to participation Age \>30 years Diagnosis of chronic heart failure, NYHA functional class I-III Left ventricular ejection fraction \<40%

Age in the registry: 30 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
2nd Department and Clinical Ward of Cardiology Specialist Hospital in Zabrze, Poland
Coordinator of this site? Confirm its status
ZabrzePolandRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.